Score Overview
Explore the 2021 public Archive ranking →
Where Amgen Inc has ranked, year by year
Showing all available years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- AMGN
1996: 13.5% · 2021: 8.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 418.13 | — |
1 Year2025-09-26 | $ 265.61 | 57.42% |
5 Years2021-09-28 | $ 181.68 | 130.14% |
10 Years2016-09-28 | $ 125.95 | 231.98% |
20 Years2006-09-28 | $ 47.76 | 8x |
30 Years1996-09-27 | $ 10.51 | 39x |
All Time1983-06-17 | $ 0.23 | 1821x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1983-06-17 |
|---|---|---|---|---|---|---|---|
| Price | $ 418.13 | $ 265.61 | $ 181.68 | $ 125.95 | $ 47.76 | $ 10.51 | $ 0.23 |
| Return | — | 57.42% | 130.14% | 231.98% | 8x | 39x | 1821x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 38.12B | $ 8.74B | $ 13.98B |
| 2025 | $ 36.74B | $ 7.71B | $ 9.12B |
| 2024 | $ 33.42B | $ 4.09B | $ 11.97B |
| 2023 | $ 28.19B | $ 6.71B | $ 10.94B |
| 2022 | $ 26.32B | $ 6.55B | $ 9.30B |
| 2021 | $ 25.97B | $ 5.89B | $ 8.03B |
| 2020 | $ 25.42B | $ 7.26B | $ 10.64B |
| 2019 | $ 23.36B | $ 7.84B | $ 8.91B |
| 2018 | $ 23.74B | $ 8.39B | $ 29.30B |
| 2017 | $ 22.84B | $ 1.97B | $ 41.67B |
| 2016 | $ 22.99B | $ 7.72B | $ 38.08B |
| 2015 | $ 21.66B | $ 6.93B | $ 31.38B |
| 2014 | $ 20.06B | $ 5.15B | $ 27.02B |
| 2013 | $ 18.67B | $ 5.08B | $ 19.40B |
| 2012 | $ 17.26B | $ 4.34B | $ 24.06B |
| 2011 | $ 15.58B | $ 3.68B | $ 20.64B |
| 2010 | $ 15.05B | $ 4.62B | $ 17.42B |
| 2009 | $ 14.64B | $ 4.60B | $ 13.44B |
| 2008 | $ 15.00B | $ 4.19B | $ 9.55B |
| 2007 | $ 14.77B | $ 3.16B | $ 7.15B |
| 2006 | $ 14.26B | $ 2.95B | $ 6.27B |
| 2005 | $ 12.43B | $ 3.67B | $ 5.25B |
| 2004 | $ 10.55B | $ 2.36B | $ 5.80B |
| 2003 | $ 8.35B | $ 2.25B | $ 5.12B |
| 2002 | $ 5.52B | -$ 1.39B | $ 4.66B |
| 2001 | $ 4.01B | $ 1.11B | $ 2.66B |
| 2000 | $ 3.44B | $ 1.13B | $ 2.02B |
| 1999 | $ 3.20B | $ 1.09B | $ 1.33B |
| 1998 | $ 2.64B | $ 863M | $ 201M |
| 1997 | $ 2.34B | $ 644M | $ 239M |
| 1996 | $ 2.19B | $ 679M | $ 169M |
| 1995 | $ 1.90B | $ 537M | $ 66M |
| 1994 | $ 1.62B | $ 319M | $ 211M |
| 1993 | $ 1.35B | $ 383M | $ 128M |
| 1992 | $ 1.08B | $ 357M | $ 92M |
| 1991 | $ 679M | $ 97M | $ 146M |
| 1990 | $ 190M | $ 19M | $ 35M |
| 1989 | $ 190M | $ 19M | $ 39M |
| 1988 | $ 70M | -$ 8M | $ 20M |
| 1987 | $ 44M | $ 1M | $ 105M |
| 1986 | $ 29M | $ 800K | $ 57M |
| 1985 | $ 21M | $ 500K | $ 66M |
Amgen Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 25.42B to $ 36.74B and net income grew from $ 7.26B to $ 7.71B. Revenue increased in every one of those 5 years; net income in 4.
Across Amgen Inc's full reported history, from 1985 to 2025, revenue grew from $ 21M to $ 36.74B and net income grew from $ 500K to $ 7.71B. Revenue increased in 90% of the years measured; net income in 68%.
Amgen Inc currently holds a 20-year HDB Score of 6.4 out of 10. How the HDB Score is calculated.
Membership
Continue AMGN’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
